AI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for IONS.
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.07% | +0.66% | +2.33% | -5.73% | -7.53% | -3.30% | +124.27% | +87.04% | +108.22% | +237.15% | +665.00% |
Aftermarket
Live · FMPLast trade
$77.94
1 sh
Bid
$71.38
51 sh
Ask
$78.00
870 sh
Spread
$6.620
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $107.27 (+40.22%)
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Ionis Pharmaceuticals, Inc. (IONS) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Ionis to host 2026 virtual Annual Meeting of Stockholdersbusinesswire.com·May 04, 2026
- Ionis to host 2026 virtual Annual Meeting of Stockholdersbusinesswire.com·May 04, 2026
- Ionis to present at upcoming investor conferencesbusinesswire.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|